Table 1.
Baseline characteristics of participants (N=201)
| Variables | Total | Low adherence |
Medium adherence |
High adherence |
| Age | ||||
| < 50 years | 138 (68.7%) | 69 (50%) | 50 (36.2%) | 19 (13.8%) |
| ≥ 50 years | 63 (31.3%) | 21 (33.3%) | 23 (36.5%) | 19 (30.2%) |
| Gender | ||||
| Male | 68 (33.8%) | 35 (51.5%) | 27 (39.7) | 6 (8.8) |
| Female | 133 (66.2%) | 55 (41.4%) | 46 (34.6) | 32 (24.1%) |
| Level of education | ||||
| ≤ Primary school | 36 (17.9%) | 11 (30.6%) | 13(36.1%) | 12 (33.3%) |
| ≥ Secondary school | 165 (82.1) | 79 (47.9%) | 60 (36.4%) | 26 (15.7%) |
| Medical insurance | ||||
| Yes | 57 (28.4%) | 26 (45.6%) | 26 (45.6%) | 5 (8.8%) |
| No | 144 (71.6%) | 64 (44.5%) | 47 (32.6%) | 33 (22.9%) |
| Last hospitalization | ||||
| < 12 months | 31 (15.5%) | 15 (48.4%) | 7 (22.6%) | 9 (29%) |
| ≥ 12 months | 170 (84.5%) | 75 (44.7%) | 66 (38.8%) | 28 (16.5%) |
| Chest physician visit | ||||
| ≤ 12 months | 140 (69.7%) | 46 (32.9%) | 57 (40.7%) | 37 (26.4%) |
| > 12 months | 61 (30.3%) | 44 (72.1) | 16 (26.2%) | 1 (1.6%) |
| Asthma duration | ||||
| ≤ 8 years | 101 (50.2%) | 47 (46.5%) | 37 (36.6%) | 17 (16.8%) |
| > 8 years | 100 (49.8%) | 43 (43%) | 36 (36%) | 21 (21%) |
| Alcohol consumption | ||||
| Yes | 39 (19.4%) | 16 (41%) | 18 (46.2%) | 5 (12.8%) |
| No | 162 (80.6%) | 74 (45.7%) | 55 (34%) | 33 (20.4%) |
| Obesity (BMI ≥ 30 kg/m2) | ||||
| No | 137 (68.1%) | 67 (48.9%) | 46 (33.6%) | 24 (17.5%) |
| Yes | 64(31.9%) | 23 (35.9%) | 27 (42.2%) | 14 (21.9%) |
| Allergic rhinitis | ||||
| Yes | 126 (62.7%) | 60 (47.6%) | 47 (37.3%) | 19 (15.1%) |
| No | 75 (37.3%) | 30 (40%) | 26 (34.7%) | 19 (25.3%) |
| Gastro-oesophageal reflux | ||||
| Yes | 28 (14.4%) | 10 (35.7) | 10 (35.7%) | 8 (28.6%) |
| No | 173 (85.6%) | 80 (46.2%) | 63 (36.4%) | 30 (17.4%) |
| Asthma controller therapy | ||||
| ICSa | 50 (24.9%) | 22 (44%) | 19 (38%) | 9 (18%) |
| ICS + LABAb | 151 (75.1%) | 67 (45%) | 54 (35.8%) | 29 (19.2%) |
| Asthma control | ||||
| Well controlled | 118 (58.7%) | 50 (42.4%) | 46 (39%) | 22 (18.6%) |
| Partly uncontrolled | 45 (22.4%) | 21 (46.7%) | 17 (37.8%) | 7 (15.6%) |
| Poorly controlled asthma | 38 (18.9%) | 19 (44.8%) | 10 (26.3%) | 9 (23.7%) |
a
ICS: Inhaled corticosteroid
b
LABA: long-acting beta-agonists